Delivery Order SPE2DB22D2206-SPE2DB25FDT84
Award Date
10/15/24
Potential Completion Date
11/5/24
Potential Value
$9.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $14,491.41 delivery order is for the supply of INQOVI 35 MG-100 MG tablets, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,740.79 firm fixed-price delivery order contract is for the supply of INQOVI 35 MG-100 MG tablets, with a completion date of April 17, 2023. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of INQOVI 35 MG-100 MG tablets. The contract has a ceiling value of $4,830.47 and a completion date of July 15, 2024. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. Amerisourcebergen, through its Corporate Office Division, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order from the Defense Logistics Agency (DLA) valued at $5,119.36. The contract is for the supply of INQOVI 35 MG-100 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has a period of performance through March 13, 2025 and is a Firm Fixed Price contract type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This federal contract award is for the delivery of INQOVI 35 MG-100 MG TABLET pharmaceutical products to the Defense Logistics Agency (DLA). The $4,830.47 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 6, 2024, with a completion date of September 27, 2024. The contract is not set aside for a specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,997.42, is for the delivery of the drug Inqovi 35 mg-100 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, with the ID SPE2DB20D2200|SPE2DB24FW76T, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,830.47 firm fixed-price delivery order is for the supply of INQOVI 35 MG-100 MG TABLET medical products. The contract has an ultimate completion date of July 9, 2024 and was awarded on June 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $4,830.47 Firm Fixed Price Delivery Order is for the provision of the drug INQOVI 35 MG-100 MG tablets, with a completion date of May 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,830.47 firm fixed price delivery order is for the supply of the medication Inqovi 35 mg-100 mg tablets. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of INQOVI 35 MG-100 MG tablets, a pharmaceutical product, with a ceiling value of $10,238.74 and a performance period ending on April 30, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of...